Background: Social cognition, particularly the ability to distinguish between self and others (i.e., theory of mind), is commonly impaired in individuals with schizophrenia.

Key Brain Region: The right temporoparietal junction (rTPJ) is a major region implicated in perspective-taking and mentalizing—processes essential for understanding others' thoughts and intentions.

Research Question: Do individuals with schizophrenia show different patterns of brain activation—especially in the rTPJ—when reflecting on themselves versus others?

Participants: Included both schizophrenia patients and healthy controls.

Task: Participants underwent fMRI while engaging in a task requiring them to reflect on either:

• Themselves,

• An acquaintance, or

• A public figure.

This allowed the researchers to distinguish between self-reflection and other-reflection in different social contexts.

Controls: Healthy participants showed increased activation in the rTPJ during other-reflection, consistent with prior literature.

Schizophrenia Patients: Showed abnormal activation patterns, with reduced differentiation between self- and other-reflection in key areas like the rTPJ, medial prefrontal cortex, and posterior cingulate.

Notably, the rTPJ did not respond selectively to other-related reflection in patients, suggesting a breakdown in normal social processing.

Individuals with schizophrenia showed reduced differentiation in brain activity between reflecting on themselves and others, particularly in the right temporoparietal junction (rTPJ).

In healthy controls, the rTPJ was selectively activated during other-reflection, consistent with its known role in theory of mind and perspective-taking.

The lack of rTPJ specificity in patients suggests a neural basis for social cognitive impairments commonly seen in schizophrenia, such as difficulty distinguishing self from others, paranoia, and delusional thinking.

Other affected regions included the medial prefrontal cortex and posterior cingulate cortex, indicating potential default mode network (DMN) dysfunction—pointing to broader network-level disruptions rather than isolated regional issues.

These findings emphasize that social cognition deficits in schizophrenia are not merely behavioural but tied to specific brain abnormalities.

Limitations of the study include a small sample size, possible effects of medication, and the complexity of capturing self-/other-reflection in a controlled task.

Background: The Brattleboro rat, genetically deficient in vasopressin, exhibits behaviours analogous to schizophrenia symptoms, such as social memory impairment and sensorimotor gating deficits.​

• Prior research suggests that vasopressin plays a role in social behaviour modulation.​

Research Question: Can chronic antipsychotic treatment ameliorate schizophrenia-like symptoms in vasopressin-deficient Brattleboro rats?

Subjects: Male vasopressin-deficient Brattleboro rats and control Long-Evans rats.​

Procedure:

• Rats were administered chronic treatments with antipsychotics: haloperidol, clozapine, and aripiprazole.​

• Behavioural assessments included tests for social recognition and prepulse inhibition (PPI) of the startle reflex to evaluate sensorimotor gating.​

Analysis: Comparisons were made between treated and untreated groups to assess the efficacy of antipsychotic interventions on schizophrenia-like behaviours.

Social Recognition:

• Untreated Brattleboro rats displayed significant deficits in social recognition compared to controls.​

• Chronic treatment with all three antipsychotics successfully normalized social recognition abilities in Brattleboro rats.​

Sensorimotor Gating (PPI):

• Brattleboro rats exhibited reduced PPI, indicating impaired sensorimotor gating.​

• Antipsychotic treatments restored PPI levels to those comparable with control rats.​

Antipsychotic treatment (haloperidol, clozapine, aripiprazole) improved both social recognition and sensorimotor gating (PPI) deficits in vasopressin-deficient Brattleboro rats.

Improvement suggests that these behaviours are responsive to dopamine-modulating treatments, supporting their validity as schizophrenia-like symptoms.

Differences in drug effectiveness:

• Aripiprazole showed strong therapeutic effects with minimal social side effects.

• Some treatments improved PPI but not social behaviours as robustly, indicating distinct neural pathways.

Chronic antipsychotic treatment reversed core schizophrenia-like symptoms in a vasopressin-deficient rat model.

Implications: Demonstrates that chronic antipsychotic therapy can improve behaviours relevant to human symptoms.

• Suggests that aripiprazole may be uniquely well-suited for preserving social motivation while treating schizophrenia, making it a strong candidate for further research.

Background:

• The Default Mode Network (DMN) is a set of interconnected brain regions active during rest and implicated in self-referential thinking and social cognition.​

• In humans, the DMN includes areas such as the medial prefrontal cortex, posterior cingulate cortex, and the right temporoparietal junction (rTPJ).​

Research Question: Do rats possess a DMN similar to that of humans and nonhuman primates, suggesting evolutionary conservation of this network?

Subjects: Adult rats were used for the study.​

Procedure: Resting-state functional MRI (rs-fMRI) was conducted under light anesthesia to detect synchronous low-frequency fluctuations indicative of functional connectivity.​

Analysis: Independent component analysis (ICA) was employed to identify networks exhibiting DMN-like activity.

Identification of Rat DMN: A network was identified in rats showing functional connectivity patterns analogous to the human DMN, including regions homologous to the medial prefrontal cortex and posterior cingulate cortex.​

Functional Connectivity: The identified rat DMN exhibited synchronous activity during rest, similar to observations in humans.

Evolutionary Conservation: The presence of a DMN in rats suggests that this network is evolutionarily conserved across mammalian species.​

Link to Schizophrenia and rTPJ: Given that the human DMN encompasses the rTPJ, the identification of a similar network in rats provides a foundation for translational studies.

Rats possess a DMN with functional connectivity patterns similar to those in humans, indicating evolutionary conservation.​

This finding supports the use of rat models to investigate DMN-related functions and dysfunctions, particularly concerning regions like the rTPJ involved in social cognition.

Implications: Rats can serve as viable models for studying DMN functionality and its role in neuropsychiatric disorders, including schizophrenia.​

Background: The neuropeptide vasopressin has been implicated in enhancing social recognition in both animals and humans.​

Research Question: Does vasopressin administration modulate neural activity in the TPJ during social recognition tasks in humans?

Subjects: Healthy male participants.​

Procedure:

• A double-blind, placebo-controlled design was used where participants received intranasal vasopressin or placebo.​

• Participants performed a face-matching task involving familiar and unfamiliar faces while undergoing functional magnetic resonance imaging (fMRI) to assess brain activity.​

Analysis: Brain activation patterns were compared between the vasopressin and placebo conditions, focusing on the TPJ region.

Vasopressin's modulation of TPJ activity suggests its role in altering neural processing related to social recognition.​

This finding aligns with vasopressin's known effects on social behavior and supports its potential therapeutic application in conditions characterized by social cognitive deficits.

Intranasal vasopressin alters activity in the left temporoparietal junction (TPJ) during social recognition tasks, reducing the neural distinction between familiar and unfamiliar faces.

Implications: Points to vasopressin-based interventions as potential therapeutic strategies for improving social cognition in clinical populations.

Main takeaway: The rTPJ is a promising neural target for future translational research aimed at improving social functioning in schizophrenia—via pharmacological, neuromodulatory, or behavioural interventions.

Implication: Disrupted rTPJ activity suggests it could be modulated to improve social cognition in schizophrenia. It also reinforces that social deficits in schizophrenia have a neurological basis, not just a behavioural one. Furthermore, it points to potential interventions targeting broader default mode network (DMN) disruptions.